Vinay Varadan

Merck & Co., Inc., Rahway, NJ, USA (United States) — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

32h-index3.5kcitations192works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Genomics and Diagnostics(37), RNA modifications and cancer(25), Radiomics and Machine Learning in Medical Imaging(25), Cancer-related molecular mechanisms research(22), Cancer Immunotherapy and Biomarkers(21)

Publications192 total

Abstract 3664: Evaluation of on-treatment tumor molecular dynamics using plasma whole genome sequencing (pWGS) and whole exome sequencing (pWES) of circulating tumor DNA (ctDNA) in patients (pts) with metastatic non-small cell lung cancer (NSCLC): An exploratory analysis of KEYNOTE-598
Cancer Research·2024
Discovery and Initial Characterization of Long Intergenic Noncoding RNAs Associated With Esophageal Adenocarcinoma
Gastroenterology·2023· 3 citedOpen Access
Supplementary Date from Multi-scale Pan-cancer Integrative Analyses Identify the STAT3-VSIR Axis as a Key Immunosuppressive Mechanism in Head and Neck Cancer
2023Open Access
Supplementary Sheet from Radiogenomic-Based Survival Risk Stratification of Tumor Habitat on Gd-T1w MRI Is Associated with Biological Processes in Glioblastoma
2023Open Access
Figure S5 from LIN9 and NEK2 Are Core Regulators of Mitotic Fidelity That Can Be Therapeutically Targeted to Overcome Taxane Resistance
2023Open Access
Data from Immune Signatures Following Single Dose Trastuzumab Predict Pathologic Response to PreoperativeTrastuzumab and Chemotherapy in HER2-Positive Early Breast Cancer
2023Open Access
Figure S1 from LIN9 and NEK2 Are Core Regulators of Mitotic Fidelity That Can Be Therapeutically Targeted to Overcome Taxane Resistance
2023Open Access
Figure S2 from LIN9 and NEK2 Are Core Regulators of Mitotic Fidelity That Can Be Therapeutically Targeted to Overcome Taxane Resistance
2023Open Access
Figure S4 from LIN9 and NEK2 Are Core Regulators of Mitotic Fidelity That Can Be Therapeutically Targeted to Overcome Taxane Resistance
2023Open Access
Data from RNA Sequencing Identifies Transcriptionally Viable Gene Fusions in Esophageal Adenocarcinomas
2023Open Access
Data from RNA Sequencing Identifies Transcriptionally Viable Gene Fusions in Esophageal Adenocarcinomas
2023Open Access
Figure S1 from LIN9 and NEK2 Are Core Regulators of Mitotic Fidelity That Can Be Therapeutically Targeted to Overcome Taxane Resistance
2023Open Access
Supplementary Date from Multi-scale Pan-cancer Integrative Analyses Identify the STAT3-VSIR Axis as a Key Immunosuppressive Mechanism in Head and Neck Cancer
2023Open Access
Supplementary Date from Multi-scale Pan-cancer Integrative Analyses Identify the STAT3-VSIR Axis as a Key Immunosuppressive Mechanism in Head and Neck Cancer
2023Open Access
Supplementary Figures from RNA Sequencing Identifies Transcriptionally Viable Gene Fusions in Esophageal Adenocarcinomas
2023Open Access
Supplementary Materials from LIN9 and NEK2 Are Core Regulators of Mitotic Fidelity That Can Be Therapeutically Targeted to Overcome Taxane Resistance
2023Open Access
Figure S3 from LIN9 and NEK2 Are Core Regulators of Mitotic Fidelity That Can Be Therapeutically Targeted to Overcome Taxane Resistance
2023Open Access
Data from LIN9 and NEK2 Are Core Regulators of Mitotic Fidelity That Can Be Therapeutically Targeted to Overcome Taxane Resistance
2023Open Access
Supplemental Figures and Tables from Immune Signatures Following Single Dose Trastuzumab Predict Pathologic Response to PreoperativeTrastuzumab and Chemotherapy in HER2-Positive Early Breast Cancer
2023Open Access
Figure S6 from LIN9 and NEK2 Are Core Regulators of Mitotic Fidelity That Can Be Therapeutically Targeted to Overcome Taxane Resistance
2023Open Access
page 1 of 10Next →

Frequent Co-authors

Salendra Singh(13), Nevenka Dimitrova(10), Lyndsay N. Harris(9), Sitharthan Kamalakaran(8), Henry Leung(8), Anant Madabhushi(7), Angel Janevski(6), Nilanjana Banerjee(6), Joseph Willis(6), Prateek Prasanna(5), Niha Beig(5), Kaustav Bera(5), Kishore Guda(5), Sanford D. Markowitz(5), Hannah Gilmore(4), Dimitris Anastassiou(4), Pallavi Tiwari(4), Lakshmeswari Ravi(4), Srividya Venkitachalam(4), Amitabh Chak(4)